Target,Name in screen,Sp.,Type,Action,Affinity (-log10),Units,Affinity (nM),Unitsepidermal growth factor receptor,"EGFR(L747-T751del,Sins)",Hs,Inhibitor,Inhibition,9.3,pKd,0.5,Kdepidermal growth factor receptor,EGFR(E746-A750del),Hs,Inhibitor,Inhibition,9.3,pKd,0.5,Kdepidermal growth factor receptor,"EGFR(L747-E749del, A750P)",Hs,Inhibitor,Inhibition,9.2,pKd,0.6,Kdepidermal growth factor receptor,"EGFR(L747-S752del, P753S)",Hs,Inhibitor,Inhibition,9.2,pKd,0.6,Kdepidermal growth factor receptor,EGFR(L858R),Hs,Inhibitor,Inhibition,9,pKd,0.9,Kdepidermal growth factor receptor,EGFR(S752-I759del),Hs,Inhibitor,Inhibition,9,pKd,1,Kdepidermal growth factor receptor,EGFR,Hs,Inhibitor,Inhibition,9,pKd,1,Kdepidermal growth factor receptor,EGFR(G719S),Hs,Inhibitor,Inhibition,9,pKd,1.1,Kdepidermal growth factor receptor,EGFR(L861Q),Hs,Inhibitor,Inhibition,8.9,pKd,1.4,Kdepidermal growth factor receptor,EGFR(G719C),Hs,Inhibitor,Inhibition,8.7,pKd,2,Kdcyclin G associated kinase,GAK,Hs,Inhibitor,Inhibition,7.9,pKd,13,Kdepidermal growth factor receptor,EGFR(T790M),Hs,Inhibitor,Inhibition,7.4,pKd,40,Kdinterleukin 1 receptor associated kinase 1,IRAK1,Hs,Inhibitor,Inhibition,7.2,pKd,69,Kdepidermal growth factor receptor,"EGFR(L858R,T790M)",Hs,Inhibitor,Inhibition,6.8,pKd,140,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(Q252H)-phosphorylated,Hs,Inhibitor,Inhibition,6.6,pKd,230,Kdmitogen-activated protein kinase kinase kinase 19,YSK4,Hs,Inhibitor,Inhibition,6.6,pKd,240,KdMAP kinase interacting serine/threonine kinase 1,MKNK1,Hs,Inhibitor,Inhibition,6.5,pKd,290,Kdhomeodomain interacting protein kinase 4,HIPK4,Hs,Inhibitor,Inhibition,6.5,pKd,310,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(Y253F)-phosphorylated,Hs,Inhibitor,Inhibition,6.4,pKd,360,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(E255K)-phosphorylated,Hs,Inhibitor,Inhibition,6.4,pKd,400,Kderb-b2 receptor tyrosine kinase 4,ERBB4,Hs,Inhibitor,Inhibition,6.4,pKd,410,Kdcasein kinase 1 epsilon,CSNK1E,Hs,Inhibitor,Inhibition,6.4,pKd,430,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(H396P)-phosphorylated,Hs,Inhibitor,Inhibition,6.3,pKd,460,Kdserine/threonine kinase 10,LOK,Hs,Inhibitor,Inhibition,6.3,pKd,470,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1-phosphorylated,Hs,Inhibitor,Inhibition,6.3,pKd,480,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(M351T)-phosphorylated,Hs,Inhibitor,Inhibition,6.3,pKd,520,Kdreceptor interacting serine/threonine kinase 2,RIPK2,Hs,Inhibitor,Inhibition,6.3,pKd,530,Kdinterleukin 1 receptor associated kinase 4,IRAK4,Hs,Inhibitor,Inhibition,6.3,pKd,540,KdSH3 domain binding kinase 1,SBK1,Hs,Inhibitor,Inhibition,6.3,pKd,560,KdEPH receptor A6,EPHA6,Hs,Inhibitor,Inhibition,6.2,pKd,590,Kdmitogen-activated protein kinase kinase 5,MEK5,Hs,Inhibitor,Inhibition,6.2,pKd,600,Kdcyclin-dependent kinase 7,CDK7,Hs,Inhibitor,Inhibition,6.2,pKd,610,Kd"LCK proto-oncogene, Src family tyrosine kinase",LCK,Hs,Inhibitor,Inhibition,6.2,pKd,630,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(H396P)-nonphosphorylated,Hs,Inhibitor,Inhibition,6.2,pKd,680,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(F317L)-phosphorylated,Hs,Inhibitor,Inhibition,6.1,pKd,780,Kderb-b2 receptor tyrosine kinase 3,ERBB3,Hs,Inhibitor,Inhibition,6.1,pKd,790,Kdcheckpoint kinase 2,CHEK2,Hs,Inhibitor,Inhibition,6.1,pKd,800,KdSTE20 like kinase,SLK,Hs,Inhibitor,Inhibition,6,pKd,920,Kd"LYN proto-oncogene, Src family tyrosine kinase",LYN,Hs,Inhibitor,Inhibition,6,pKd,990,Kdfms related tyrosine kinase 3,FLT3(D835Y),Hs,Inhibitor,Inhibition,6,pKd,1000,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(Q252H)-nonphosphorylated,Hs,Inhibitor,Inhibition,6,pKd,1100,Kdfms related tyrosine kinase 3,FLT3(D835H),Hs,Inhibitor,Inhibition,6,pKd,1100,Kd"BLK proto-oncogene, Src family tyrosine kinase",BLK,Hs,Inhibitor,Inhibition,5.9,pKd,1200,KdMAP kinase interacting serine/threonine kinase 2,MKNK2,Hs,Inhibitor,Inhibition,5.9,pKd,1200,Kdribosomal protein S6 kinase A4,RPS6KA4(Kin.Dom.2-C-terminal),Hs,Inhibitor,Inhibition,5.9,pKd,1200,Kdcitron rho-interacting serine/threonine kinase,CIT,Hs,Inhibitor,Inhibition,5.9,pKd,1300,KdEPH receptor B1,EPHB1,Hs,Inhibitor,Inhibition,5.9,pKd,1300,KdEPH receptor A5,EPHA5,Hs,Inhibitor,Inhibition,5.8,pKd,1500,Kdinterleukin 1 receptor associated kinase 3,IRAK3,Hs,Inhibitor,Inhibition,5.8,pKd,1500,Kd"ABL proto-oncogene 2, non-receptor tyrosine kinase",ABL2,Hs,Inhibitor,Inhibition,5.8,pKd,1600,Kdmitogen-activated protein kinase 6,ERK3,Hs,Inhibitor,Inhibition,5.8,pKd,1600,Kdmitogen-activated protein kinase 9,JNK2,Hs,Inhibitor,Inhibition,5.8,pKd,1700,KdAXL receptor tyrosine kinase,AXL,Hs,Inhibitor,Inhibition,5.7,pKd,1800,KdEPH receptor A8,EPHA8,Hs,Inhibitor,Inhibition,5.7,pKd,1800,KdKIT proto-oncogene receptor tyrosine kinase,KIT(A829P),Hs,Inhibitor,Inhibition,5.7,pKd,1800,Kdmisshapen-like kinase 1,MINK,Hs,Inhibitor,Inhibition,5.7,pKd,1800,Kdmyosin light chain kinase 2,MYLK2,Hs,Inhibitor,Inhibition,5.7,pKd,1900,Kdserine/threonine kinase 17a,DRAK1,Hs,Inhibitor,Inhibition,5.7,pKd,2000,Kdfyn related Src family tyrosine kinase,FRK,Hs,Inhibitor,Inhibition,5.7,pKd,2000,Kdmitogen-activated protein kinase kinase kinase 3,MAP3K3,Hs,Inhibitor,Inhibition,5.7,pKd,2100,Kdsalt inducible kinase 2,SIK2,Hs,Inhibitor,Inhibition,5.7,pKd,2100,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1-nonphosphorylated,Hs,Inhibitor,Inhibition,5.7,pKd,2200,KdEPH receptor B4,EPHB4,Hs,Inhibitor,Inhibition,5.6,pKd,2500,Kd"FGR proto-oncogene, Src family tyrosine kinase",FGR,Hs,Inhibitor,Inhibition,5.6,pKd,2600,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(F317L)-nonphosphorylated,Hs,Inhibitor,Inhibition,5.6,pKd,2700,Kdphosphorylase kinase gamma subunit 2,PHKG2,Hs,Inhibitor,Inhibition,5.6,pKd,2700,Kddoublecortin like kinase 3,DCAMKL3,Hs,Inhibitor,Inhibition,5.5,pKd,2900,Kdfms related tyrosine kinase 3,FLT3(ITD),Hs,Inhibitor,Inhibition,5.5,pKd,2900,KdAP2 associated kinase 1,AAK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(F317I)-nonphosphorylated,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(T315I)-nonphosphorylated,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(T315I)-phosphorylated,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdactivin A receptor type 1,ACVR1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdactivin A receptor type 1B,ACVR1B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdactivin A receptor type 2A,ACVR2A,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdactivin A receptor type 2B,ACVR2B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdactivin A receptor type IL,ACVRL1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdaarF domain containing kinase 3,ADCK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdaarF domain containing kinase 4,ADCK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdv-akt murine thymoma viral oncogene homolog 1,AKT1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdv-akt murine thymoma viral oncogene homolog 2,AKT2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdv-akt murine thymoma viral oncogene homolog 3,AKT3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdanaplastic lymphoma receptor tyrosine kinase,ALK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase AMP-activated catalytic subunit alpha 1,AMPK-alpha1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase AMP-activated catalytic subunit alpha 2,AMPK-alpha2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdankyrin repeat and kinase domain containing 1,ANKK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNUAK family kinase 1,ARK5,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 5,ASK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 6,ASK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdaurora kinase A,AURKA,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdaurora kinase B,AURKB,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdaurora kinase C,AURKC,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdBMP2 inducible kinase,BIKE,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdbone morphogenetic protein receptor type IA,BMPR1A,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdbone morphogenetic protein receptor type IB,BMPR1B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdbone morphogenetic protein receptor type II,BMPR2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdBMX non-receptor tyrosine kinase,BMX,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"B-Raf proto-oncogene, serine/threonine kinase",BRAF,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"B-Raf proto-oncogene, serine/threonine kinase",BRAF(V600E),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein tyrosine kinase 6,BRK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdBR serine/threonine kinase 1,BRSK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdBR serine/threonine kinase 2,BRSK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdBruton tyrosine kinase,BTK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin-dependent protein kinase I,CAMK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin dependent protein kinase ID,CAMK1D,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin dependent protein kinase IG,CAMK1G,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin-dependent protein kinase II alpha subunit,CAMK2A,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin-dependent protein kinase II beta subunit,CAMK2B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin-dependent protein kinase II delta subunit,CAMK2D,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin-dependent protein kinase II gamma subunit,CAMK2G,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin-dependent protein kinase IV,CAMK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin-dependent protein kinase kinase 1,CAMKK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin-dependent protein kinase kinase 2,CAMKK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcalcium/calmodulin-dependent serine protein kinase (MAGUK family),CASK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 11B,CDC2L1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 11A,CDC2L2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 13,CDC2L5,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 19,CDK11,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 2,CDK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 3,CDK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 4,CDK4-cyclinD1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 4,CDK4-cyclinD3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 5,CDK5,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 8,CDK8,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 9,CDK9,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin dependent kinase like 1,CDKL1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin dependent kinase like 2,CDKL2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase like 3,CDKL3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase like 4,CDKL5,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcheckpoint kinase 1,CHEK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdCDC like kinase 1,CLK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdCDC like kinase 2,CLK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdCDC like kinase 3,CLK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdCDC like kinase 4,CLK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcolony stimulating factor 1 receptor,CSF1R,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdc-src tyrosine kinase,CSK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcasein kinase 1 alpha 1,CSNK1A1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcasein kinase 1 alpha 1 like,CSNK1A1L,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcasein kinase 1 gamma 1,CSNK1G1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcasein kinase 1 gamma 2,CSNK1G2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcasein kinase 1 gamma 3,CSNK1G3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"casein kinase 2, alpha 1 polypeptide subunit",CSNK2A1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"casein kinase 2, alpha prime polypeptide subunit",CSNK2A2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmegakaryocyte-associated tyrosine kinase,CTK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddeath associated protein kinase 1,DAPK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddeath-associated protein kinase 2,DAPK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddoublecortin like kinase 1,DCAMKL1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddoublecortin like kinase 2,DCAMKL2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddiscoidin domain receptor tyrosine kinase 1,DDR1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddiscoidin domain receptor tyrosine kinase 2,DDR2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 12,DLK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdCDC42 binding protein kinase gamma,DMPK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddual specificity tyrosine phosphorylation regulated kinase 1A,DYRK1A,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddual specificity tyrosine phosphorylation regulated kinase 1B,DYRK1B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddual specificity tyrosine phosphorylation regulated kinase 2,DYRK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdeukaryotic translation initiation factor 2 alpha kinase 1,EIF2AK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdEPH receptor A2,EPHA2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdEPH receptor A4,EPHA4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdEPH receptor A7,EPHA7,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdEPH receptor B2,EPHB2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdEPH receptor B3,EPHB3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 3,ERK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 1,ERK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 7,ERK5,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 15,ERK8,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdendoplasmic reticulum to nucleus signaling 1,ERN1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein tyrosine kinase 2,FAK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdFER tyrosine kinase,FER,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"FES proto-oncogene, tyrosine kinase",FES,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdfibroblast growth factor receptor 1,FGFR1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdfibroblast growth factor receptor 2,FGFR2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdfibroblast growth factor receptor 3,FGFR3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdfibroblast growth factor receptor 3,FGFR3(G697C),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdfibroblast growth factor receptor 4,FGFR4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdfms related tyrosine kinase 1,FLT1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdfms related tyrosine kinase 3,FLT3(N841I),Hs,Inhibitor,Inhibition,5.5,pKd,3000,Kdfms related tyrosine kinase 4,FLT4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"FYN proto-oncogene, Src family tyrosine kinase",FYN,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdeukaryotic translation initiation factor 2 alpha kinase 4,"GCN2(Kin.Dom.2,S808G)",Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdG protein-coupled receptor kinase 1,GRK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdG protein-coupled receptor kinase 4,GRK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdG protein-coupled receptor kinase 7,GRK7,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdglycogen synthase kinase 3 alpha,GSK3A,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdglycogen synthase kinase 3 beta,GSK3B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdhomeodomain interacting protein kinase 1,HIPK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdhomeodomain interacting protein kinase 2,HIPK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdhomeodomain interacting protein kinase 3,HIPK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase kinase 1,HPK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdhormonally up-regulated Neu-associated kinase,HUNK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdintestinal cell (MAK-like) kinase,ICK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdInsulin-like growth factor I receptor,IGF1R,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdconserved helix-loop-helix ubiquitous kinase,IKK-alpha,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta",IKK-beta,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon",IKK-epsilon,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdInsulin receptor,INSR,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdInsulin receptor-related receptor,INSRR,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdIL2 inducible T-cell kinase,ITK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdJanus kinase 1,JAK1(JH1domain-catalytic),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdJanus kinase 1,JAK1(JH2domain-pseudokinase),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdJanus kinase 2,JAK2(JH1domain-catalytic),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdJanus kinase 3,JAK3(JH1domain-catalytic),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 8,JNK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdKIT proto-oncogene receptor tyrosine kinase,KIT,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdKIT proto-oncogene receptor tyrosine kinase,KIT(L576P),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdKIT proto-oncogene receptor tyrosine kinase,KIT(V559D),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdKIT proto-oncogene receptor tyrosine kinase,"KIT(V559D,T670I)",Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdKIT proto-oncogene receptor tyrosine kinase,"KIT(V559D,V654A)",Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdlarge tumor suppressor kinase 1,LATS1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdlarge tumor suppressor kinase 2,LATS2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdLIM domain kinase 1,LIMK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdLIM domain kinase 2,LIMK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 11,LKB1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdleucine-rich repeat kinase 2,LRRK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdleucine-rich repeat kinase 2,LRRK2(G2019S),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 13,LZK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmale germ cell associated kinase,MAK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 1,MAP3K1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 15,MAP3K15,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 4,MAP3K4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase kinase 2,MAP4K2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase kinase 3,MAP4K3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase kinase 4,MAP4K4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase kinase 5,MAP4K5,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase-activated protein kinase 2,MAPKAPK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase-activated protein kinase 5,MAPKAPK5,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmicrotubule affinity regulating kinase 1,MARK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmicrotubule affinity regulating kinase 2,MARK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmicrotubule affinity regulating kinase 3,MARK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmicrotubule affinity regulating kinase 4,MARK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdMicrotubule associated serine/threonine kinase 1,MAST1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase 1,MEK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase 2,MEK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase 3,MEK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase 4,MEK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase 6,MEK6,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmaternal embryonic leucine zipper kinase,MELK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"MER proto-oncogene, tyrosine kinase",MERTK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"MET proto-oncogene, receptor tyrosine kinase",MET,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"MET proto-oncogene, receptor tyrosine kinase",MET(M1250T),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase 7,MKK7,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmyosin light chain kinase 3,MLCK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 9,MLK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 10,MLK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 11,MLK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdCDC42 binding protein kinase alpha,MRCKA,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdCDC42 binding protein kinase beta,MRCKB,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 4,MST1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmacrophage stimulating 1 receptor,MST1R,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 3,MST2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 24,MST3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine-protein kinase MST4,MST4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmechanistic target of rapamycin,MTOR,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"muscle, skeletal, receptor tyrosine kinase",MUSK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmyosin light chain kinase,MYLK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmyosin light chain kinase family member 4,MYLK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmyosin IIIA,MYO3A,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmyosin IIIB,MYO3B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdSerine/threonine kinase 38,NDR1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdSerine/threonine kinase 38 like,NDR2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNIMA related kinase 1,NEK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNIMA related kinase 11,NEK11,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNIMA related kinase 2,NEK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNIMA related kinase 3,NEK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNIMA related kinase 4,NEK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNIMA related kinase 5,NEK5,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNIMA related kinase 6,NEK6,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNIMA related kinase 7,NEK7,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdNIMA related kinase 8,NEK9,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine-protein kinase NIM1,NIM1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdoxidative stress responsive 1,OSR1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 14,p38-alpha,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 11,p38-beta,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 13,p38-delta,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 12,p38-gamma,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdp21 protein (Cdc42/Rac)-activated kinase 1,PAK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdp21 protein (Cdc42/Rac)-activated kinase 2,PAK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdp21 protein (Cdc42/Rac)-activated kinase 3,PAK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdp21 protein (Cdc42/Rac)-activated kinase 4,PAK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdp21 protein (Cdc42/Rac)-activated kinase 6,PAK6,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdp21 protein (Cdc42/Rac)-activated kinase 7,PAK7,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 16,PCTK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 17,PCTK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 18,PCTK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdplatelet derived growth factor receptor alpha,PDGFRA,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdplatelet derived growth factor receptor beta,PDGFRB,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd3-phosphoinositide dependent protein kinase 1,PDPK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 15,PFTAIRE2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdcyclin-dependent kinase 14,PFTK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdphosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta,PIK3C2B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdphosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma,PIK3C2G,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA(C420R),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA(E542K),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA(E545A),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA(E545K),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA(H1047L),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA(H1047Y),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA(I800L),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA(M1043I),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",PIK3CA(Q546K),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",PIK3CB,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",PIK3CD,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",PIK3CG,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdphosphatidylinositol 4-kinase alpha,PIK4CB,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"Pim-1 proto-oncogene, serine/threonine kinase",PIM1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"Pim-2 proto-oncogene, serine/threonine kinase",PIM2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4-phosphate 5-kinase, type I, alpha",PIP5K1A,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-4-phosphate 5-kinase, type I, gamma",PIP5K1C,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"phosphatidylinositol-5-phosphate 4-kinase, type II, beta",PIP5K2B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"protein kinase, cAMP-dependent, catalytic, alpha subunit",PKAC-alpha,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"protein kinase, cAMP-dependent, catalytic, beta subunit",PKAC-beta,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"protein kinase, membrane associated tyrosine/threonine 1",PKMYT1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase N1,PKN1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase N2,PKN2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdpolo like kinase 1,PLK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdpolo like kinase 2,PLK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdpolo like kinase 3,PLK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdpolo like kinase 4,PLK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase C delta,PRKCD,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase C epsilon,PRKCE,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase C eta,PRKCH,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase C iota,PRKCI,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase C theta,PRKCQ,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase D2,PRKD2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein kinase D3,PRKD3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdProtein kinase G (PKG) 1,PRKG1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdProtein kinase G (PKG) 2,PRKG2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdeukaryotic translation initiation factor 2 alpha kinase 2,PRKR,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"protein kinase, X-linked",PRKX,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdpre-mRNA processing factor 4B,PRP4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdprotein tyrosine kinase 2 beta,PYK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdSIK family kinase 3,QSK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"Raf-1 proto-oncogene, serine/threonine kinase",RAF1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdret proto-oncogene,RET,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdret proto-oncogene,RET(M918T),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdret proto-oncogene,RET(V804L),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdret proto-oncogene,RET(V804M),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdRIO kinase 1,RIOK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdRIO kinase 2,RIOK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdRIO kinase 3,RIOK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdreceptor interacting serine/threonine kinase 1,RIPK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdreceptor interacting serine/threonine kinase 4,RIPK4,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kddual serine/threonine and tyrosine protein kinase,RIPK5,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdRho associated coiled-coil containing protein kinase 1,ROCK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdRho associated coiled-coil containing protein kinase 2,ROCK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"c-ros oncogene 1, receptor tyrosine kinase",ROS1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A4,RPS6KA4(Kin.Dom.1-N-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A5,RPS6KA5(Kin.Dom.1-N-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A5,RPS6KA5(Kin.Dom.2-C-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A1,RSK1(Kin.Dom.1-N-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A1,RSK1(Kin.Dom.2-C-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A3,RSK2(Kin.Dom.1-N-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A2,RSK3(Kin.Dom.1-N-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A2,RSK3(Kin.Dom.2-C-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A6,RSK4(Kin.Dom.1-N-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase A6,RSK4(Kin.Dom.2-C-terminal),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdribosomal protein S6 kinase B1,S6K1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdsugen kinase 110,SgK110,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserum/glucocorticoid regulated kinase family member 3,SGK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdsalt inducible kinase 1,SIK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdSNF related kinase,SNRK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdsrc-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites,SRMS,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdSRSF protein kinase 1,SRPK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdSRSF protein kinase 2,SRPK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdSRSF protein kinase 3,SRPK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 16,STK16,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 33,STK33,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 35,STK35,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 39,STK39,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdspleen tyrosine kinase,SYK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase kinase kinase 7,TAK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdTAO kinase 1,TAOK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdTAO kinase 2,TAOK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdTAO kinase 3,TAOK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdTANK binding kinase 1,TBK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtec protein tyrosine kinase,TEC,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtestis-specific kinase 1,TESK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtransforming growth factor beta receptor 1,TGFBR1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtransforming growth factor beta receptor II,TGFBR2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtyrosine kinase with immunoglobulin like and EGF like domains 1,TIE1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdTEK receptor tyrosine kinase,TIE2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtousled like kinase 1,TLK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtousled like kinase 2,TLK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"tyrosine kinase, non-receptor, 1",TNK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"tyrosine kinase, non-receptor, 2",TNK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdTNNI3 interacting kinase,TNNI3K,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"neurotrophic tyrosine kinase, receptor, type 1",TRKA,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdneurotrophic tyrosine kinase receptor type 2,TRKB,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"neurotrophic tyrosine kinase, receptor, type 3",TRKC,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdTRPM6,TRPM6,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtestis specific serine kinase 1B,TSSK1B,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdTTK protein kinase,TTK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtyrosine kinase 2,TYK2(JH1domain-catalytic),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdtyrosine kinase 2,TYK2(JH2domain-pseudokinase),Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdTYRO3 protein tyrosine kinase,TYRO3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdunc-51 like autophagy activating kinase 1,ULK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdunc-51 like autophagy activating kinase 2,ULK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdunc-51 like kinase 3,ULK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdkinase insert domain receptor,VEGFR2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdvaccinia related kinase 2,VRK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdWEE1 G2 checkpoint kinase,WEE1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdWEE1 homolog 2 (S. pombe),WEE2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 32A,YANK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 32B,YANK2,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 32C,YANK3,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kd"YES proto-oncogene 1, Src family tyrosine kinase",YES,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdserine/threonine kinase 25,YSK1,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,KdZAK sterile alpha motif and leucine zipper containing kinase AZK,ZAK,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdzeta chain of T cell receptor associated protein kinase 70kDa,ZAP70,Hs,Inhibitor,Inhibition,<5.5,pKd,>3000.0,Kdmitogen-activated protein kinase 4,ERK4,Hs,Inhibitor,Inhibition,5.5,pKd,3100,Kdfms related tyrosine kinase 3,FLT3,Hs,Inhibitor,Inhibition,5.5,pKd,3100,Kdcasein kinase 1 delta,CSNK1D,Hs,Inhibitor,Inhibition,5.5,pKd,3200,KdEPH receptor B6,EPHB6,Hs,Inhibitor,Inhibition,5.5,pKd,3200,Kdmitogen-activated protein kinase 10,JNK3,Hs,Inhibitor,Inhibition,5.5,pKd,3200,Kdmitogen-activated protein kinase kinase kinase 2,MAP3K2,Hs,Inhibitor,Inhibition,5.5,pKd,3300,Kderb-b2 receptor tyrosine kinase 2,ERBB2,Hs,Inhibitor,Inhibition,5.5,pKd,3500,Kdfms related tyrosine kinase 3,FLT3(R834Q),Hs,Inhibitor,Inhibition,5.5,pKd,3500,Kd"MET proto-oncogene, receptor tyrosine kinase",MET(Y1235D),Hs,Inhibitor,Inhibition,5.5,pKd,3500,Kdprotein kinase D1,PRKD1,Hs,Inhibitor,Inhibition,5.5,pKd,3500,Kdphosphorylase kinase gamma subunit 1,PHKG1,Hs,Inhibitor,Inhibition,5.4,pKd,3700,Kdserine/threonine kinase 17b,DRAK2,Hs,Inhibitor,Inhibition,5.4,pKd,3800,Kd"SRC proto-oncogene, non-receptor tyrosine kinase",SRC,Hs,Inhibitor,Inhibition,5.4,pKd,3800,KdEPH receptor A1,EPHA1,Hs,Inhibitor,Inhibition,5.4,pKd,4000,Kdnemo-like kinase,NLK,Hs,Inhibitor,Inhibition,5.4,pKd,4200,KdKIT proto-oncogene receptor tyrosine kinase,KIT(D816V),Hs,Inhibitor,Inhibition,5.4,pKd,4300,Kd"HCK proto-oncogene, Src family tyrosine kinase",HCK,Hs,Inhibitor,Inhibition,5.4,pKd,4400,Kd"NUAK family, SNF1-like kinase, 2",SNARK,Hs,Inhibitor,Inhibition,5.3,pKd,4600,Kd"ABL proto-oncogene 1, non-receptor tyrosine kinase",ABL1(F317I)-phosphorylated,Hs,Inhibitor,Inhibition,5.3,pKd,4700,Kdfms related tyrosine kinase 3,FLT3(K663Q),Hs,Inhibitor,Inhibition,5.3,pKd,5100,KdEPH receptor A3,EPHA3,Hs,Inhibitor,Inhibition,5.3,pKd,5500,KdKIT proto-oncogene receptor tyrosine kinase,KIT(D816H),Hs,Inhibitor,Inhibition,5.3,pKd,5500,Kdleukocyte receptor tyrosine kinase,LTK,Hs,Inhibitor,Inhibition,5.3,pKd,5500,Kddeath-associated protein kinase 3,DAPK3,Hs,Inhibitor,Inhibition,5.2,pKd,5700,Kdserine/threonine kinase 36,STK36,Hs,Inhibitor,Inhibition,5.2,pKd,5700,Kd"Pim-3 proto-oncogene, serine/threonine kinase",PIM3,Hs,Inhibitor,Inhibition,5.2,pKd,5800,KdTXK tyrosine kinase,TXK,Hs,Inhibitor,Inhibition,5.2,pKd,6000,Kddystrophia myotonica protein kinase,DMPK,Hs,Inhibitor,Inhibition,5.2,pKd,6900,KdTRAF2 and NCK interacting kinase,TNIK,Hs,Inhibitor,Inhibition,5.2,pKd,6900,Kd"phosphatidylinositol-5-phosphate 4-kinase, type II, gamma",PIP5K2C,Hs,Inhibitor,Inhibition,5.1,pKd,7500,Kd